Volume 76, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


The epidemiology of malaria among U.S. government personnel attached to diplomatic posts has not been reported. We reviewed malaria surveillance reports on persons with onset of symptoms between January 1988 and December 2004. Among 684 slide-proven cases, the median age was 36 years. There were 565 (82.6%) cases of malaria and 56 (8.2%) of malaria. A total of 89.9% were infected in Africa and 5.8% were infected in Asia; 95% of the cases originated in sub-Saharan Africa. One-fourth of all cases were reported in 1990–1991. The average annual incidence (per 1,000 personnel) of between 1995 and 1999 was highest in west Africa (8.96), followed by central Africa (8.08), and east Africa (4.27). No or irregular chemoprophylaxis was reported by 58.5%. Among those who indicated regular prophylaxis, 78% took regimens no longer considered adequate. In sub-Saharan Africa, cases were reported in every month. There were three deaths. Prevention of malaria among U.S. Government employees attached to diplomatic posts should particularly focus on those serving in sub-Saharan Africa and malarious areas of Asia.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. World Health Organization, 2006. Global Malaria Program. Accessed June 29, 2006. Available from http://www.who.int/malaria/epidemicsandemergencies.html
  2. World Health Organization, 1997. World malaria situation in 1994. Wkly Epidemiol Rec 72 : 269–274, 277–283. [Google Scholar]
  3. Berman JG, 2001. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am J Trop Med Hyg 64 (Suppl 1–2): 1–11. [Google Scholar]
  4. Sachs JD, 2005. Achieving the millennium development goals—The case of malaria. N Engl J Med 352 : 115–117. [Google Scholar]
  5. Centers for Disease Control and Prevention, 2006. Malaria Surveillance—United States, 2004. MMWR Morb Mortal Wkly Rep 55 : 23–37 [Google Scholar]
  6. Newman RD, Parise ME, Barber AM, Steketee RW, 2004. Malaria-related deaths among U.S. Travelers, 1963–2001. Ann Intern Med 141 : 547–555. [Google Scholar]
  7. Jelinek T, Schulte C, Behrens R, Grobusch MP, Couland JP, Bisoffi Z, Matteelli A, Clerinx J, Corachan M, Puente S, Gjorup I, Harms G, Kollaritsch H, Kotlowski A, Bjorkmann A, Delmont JP, Knobloch J, Nielsen LN, Cuadros J, Hatz C, Beran J, Schmid ML, Schulze M, Lopez-Velez R, Fleischer K, Kapaun A, McWhinney P, Kern P, Atougia J, Fry G, da Cunha S, Goecken B, for the European Network on Surveillance of Imported Infectious Diseases (TropNetEurop), 2002. Imported falciparum malaria in Europe: sentinel Surveillance data from the European Network on surveillance of imported infectious diseases. Clin Infect Dis 34 : 572–576. [Google Scholar]
  8. World Health Organization, 2006. Malaria in Travelers. Accessed April 27, 2006. Available from www.who.int/malaria/malariaandtravellers.html
  9. Frame JD, Lange WE, Frankenfield DL, 1992. Mortality trends of American missionaries in Africa, 1945–1985. Am J Trop Med Hyg 46 : 686–690. [Google Scholar]
  10. Beadle C, Hoffman SL, 1993. History of malaria in the United States Naval Forces at war: World War I through the Vietnam conflict. Clin Infect Dis 16 : 320–329. [Google Scholar]
  11. Newton JA, Schnepf GA, Wallace MR, Lobel HO, Kennedy CA, Oldfield EC, 1994. Malaria in U.S. Marines returning from Somalia. JAMA 272 : 397–399. [Google Scholar]
  12. Kotwal RS, Wenzel RB, Sterling RA, Porter WD, Jordan NN, Petruccelli BP, 2005. An outbreak of malaria in U.S. Army Rangers returning from Afghanistan. JAMA 293 : 212–216. [Google Scholar]
  13. Wallace MR, Sharp TW, Smoak B, Iriye C, Rozmajzl P, Thornton SA, Batchelor R, Magill AJ, Lobel JO, Longer CF, Burans JP, 1996. Malaria among United States Troops in Somalia. Am J Med 100 : 49–55. [Google Scholar]
  14. Susi B, Whitman T, Blazes DL, Burgess TH, Martin GJ, Freilich D, 2005. Rapid diagnostic test for Plasmodium falciparum in 32 Marines medically evacuated from Liberia with a febrile illness. Ann Intern Med 142 : 476–477. [Google Scholar]
  15. Lobel HO, Miani M, Eng T, Bernard KW, Hightower AW, Campbell CC, 1993. Long-term malaria prophylaxis with weekly mefloquine. Lancet 341 : 848–851. [Google Scholar]
  16. Centers for Disease Control and Prevention, 2006. Malaria in multiple family members—Chicago, Illinois. MMWR Morb Mortal Wkly Rep 55 : 645–648. [Google Scholar]
  17. Centers for Disease Control and Prevention, 2005. Health Information for International Travelers, 2005–2006. Accessed August 1, 2006. Available from www.cdc.gov/travel/destinat.htm
  18. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, von Sonnenburg F, Keystone JS, Pandey P, Cetron MS for the GeoSentinel Surveillance Network, 2006. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 354 : 119–130. [Google Scholar]
  19. Marx A, Pewsner D, Egger M, Nuesch R, Bucher HC, Genton B, Hatz C, Juni P, 2005. Meta-analysis: accuracy of rapid tests for malaria in travelers returning from endemic areas. Ann Intern Med 142 : 836–846. [Google Scholar]
  20. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA, 2006. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 42 : 377–382. [Google Scholar]
  21. Muhlberger N, Jelinek T, Behrens RH, Gjorup I, Couland JP, Clerinx J, Puente S, Burchard G, Gascon J, Grobusch MP, Weitzel T, Zoller T, Kollaritsch H, Beran J, Iversen J, Hatz C, Schmid ML, Bjorkman A, Fleischer K, Bisoffi Z, Guggemos W, Knobloch J, Matelli A, Schulze H, Laferi H, Kapaun A, McWhinney P, Lopez-Velz R, Fatkenheuer G, Kern P, Zieger BW, Kotlowski A, Fry G, Cuadros J, Myrvang B for the Trop-NetEurop and Surveillance Importierter Infectionen in Deutschland (SIMPID) Surveillance Networks, 2003. Age as a risk factor for severe manifestations and fatal outcome of falciparum malaria in European patients: Observations from the TropNetEurop and SSIMPID surveillance data. Clin Infect Dis 36 : 990–995. [Google Scholar]
  22. Remme JHE, Binka E, Nabarro D, 2001. Toward a framework and indicators for monitoring Roll Back Malaria. Am J Trop Med Hyg 64 (Suppl 1–2): 76–84. [Google Scholar]
  23. Centers for Disease Control and Prevention, 1995. Malaria Surveillance United States—1992. MMWR CDC Surveill Summ 44 (SS-5): 1–15. Available at http://www.cdc.gov/mmwr/preview/mmwrhtml/00039398.htm. [Google Scholar]
  24. Willaims HA, Roberts J, Kachur SP, Barber AM, Barat LM, Bloland PB, Ruebush TK II, Wolfe EB, 1999. Malaria Surveillance–United States, 1995. MMWR CDC Surveill Summ 48 : 1–23. [Google Scholar]
  25. Askling HH, Nilsson J, Tegnell A, Janzon R, Ekdahl K, 2005. Malaria risk in travelers. Emerg Infect Dis 11 : 436–441. [Google Scholar]
  26. Ling J, Baird JK, Fryauff DJ, Sismadi P, Bangs MJ, Lacy M, Barcus MJ, Gramzinski R, Maguire JD, Kumusumangsih M, Miller GB, Jones TR, Chulay JD, Hoffman SL, and the Naval Medical Research Unit 2 Clinical Trial Team, 2002. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Clin Infect Dis 35 : e25–e35. [Google Scholar]
  27. Schwartz E, Parise M, Kozarsky P, Cetron M, 2003. Delayed onset of malaria—Implications for chemoprophylaxis in travelers. N Engl J Med 349 : 1510–1516. [Google Scholar]
  28. Baird JK, Fryauff DJ, Hoffman SL, 2003. Primaquine for prevention of malaria in travelers. Clin Infect Dis 37 : 1659–1667. [Google Scholar]
  29. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg 75 : 402–415. [Google Scholar]
  30. Centers for Disease Control, 1987. Chloroquine-resistant Plasmodium falciparum malaria in west Africa. MMWR Morb Mortal Wkly Rep 36 : 13–14. [Google Scholar]
  31. Centers for Disease Control and Prevention, 1988. Current trends. Recommendations for the prevention of malaria in travelers. MMWR Morb Mortal Wkly Rep 37 : 277–284. [Google Scholar]
  32. Adera T, Wolfe MS, McGuire-Rugh K, Calhoun N, Marum L, 1995. Risk factors for malaria among expatriates living in Kampala, Uganda: the need for adherence to chemoprophylactic regimens. Am J Trop Med Hyg 52 : 206–212. [Google Scholar]
  33. Centers for Disease Control and Prevention, 1991. Notice to readers: change in dosing regimen for malaria prophylaxis with mefloquine. MMWR Morb Mortal Wkly Rep 40 : 72–73. [Google Scholar]
  34. Anonymous, 2000. Atovaquone/proguanil (Malarone) for malaria. The Medical Letter 42 : 109–111 [Google Scholar]
  35. Centers for Disease Control and Prevention, 2003. Health Information for International Travel, 2003–2004. Atlanta: Centers for Disease Control and Prevention.
  36. Krause G, Schöneberg I, Altmann D, Stark K, 2006. Chemoprophylaxis and malaria death rates. Emerg Infect Dis 12 : 447–451. [Google Scholar]
  37. World Health Organization Study Group, 2006. Malaria vector control and personal protection. World Health Organ Tech Rep Ser 936 : 1–62. [Google Scholar]
  38. Maguire JD, Krisin, Marwoto H, Richie TL, Fryauff DJ, Baird JK, 2006. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin Infect Dis 42 : 1067–1072. [Google Scholar]
  39. Molle I, Christensen K, 2000. Use of medical chemoprophylaxis and anti-mosquito precautions in Danish malaria patients and their traveling companions. J Travel Med 7 : 253–258. [Google Scholar]
  40. Kain KC, Shanks GD, Keystone JS, 2001. Malaria chemoprophylaxis in the age of drug resistance. I. Currently recommended drug regimens. Clin Infect Dis 33 : 226–234. [Google Scholar]
  41. Schlagenhauf P, Tschopp A, Johnson R, Nothdurft HD, Beck B, Schwartz E, Herold M, Krebs B, Veit O, Allwinn R, Steffen R, 2003. Tolerability of malaria chemoprophylaxis in non-immune travelers to sub-Saharan Africa: Multicentre, randomized, double blind, four arm study. BMJ 327 : 1078–1083. [Google Scholar]
  42. Centers for Disease Control and Prevention, 1984. Revised recommendations for preventing malaria in travelers to areas with chloroquine-resistant Plasmodium falciparum. MMWR Morb Mortal Wkly Rep 34 : 185–190. [Google Scholar]
  43. Centers for Disease Control, 1986. Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. MMWR Morb Mortal Wkly Rep 35 : 165–166. [Google Scholar]
  44. Farcas GA, Soeller R, Zhong K, Zahirieh A, Kain KC, 2006. Real-time polymerase chain reaction assay for the detection and characterization of chloroquine-resistant Plasmodium falciparum malaria in returned travelers. Clin Infect Dis 42 : 622–627. [Google Scholar]
  45. Guyatt HL, Snow RW, 2001. The epidemiology and burden of Plasmodium falciparum-related anemia among pregnant women in sub-Saharan Africa. Am J Trop Med Hyg 64 (Suppl 1–2): 36–44. [Google Scholar]
  46. Centers for Disease Control and Prevention, Information for Health Care Providers: Preventing Malaria in Pregnant Woman. Accessed August 1, 2006. Available form http://www.cdc.gov/travel/mal_preg_hc.htm
  47. Fischer PR, Bialek R, 2002. Prevention of malaria in children. Clin Infect Dis 34 : 493–498. [Google Scholar]
  48. Centers for Disease Control and Prevention, 2006. Prevention of Malaria in Children. Accessed June 29, 2006. Available from www.cdc.gov/malaria and www.cdc.gov/travel

Data & Media loading...

  • Received : 11 Aug 2006
  • Accepted : 02 Oct 2006

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error